Isr Med Assoc J. 2004 May;6(5):271-5.

Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.

Source

Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel. nweintrob@clalit.org.il

Abstract

CSII is a feasible, safe and well-accepted mode of therapy for many children with type 1 diabetes. For a significant number of patients and parents, it serves as a much easier means of coping with the huge daily burden of diabetes. Therefore, we believe that both CSII and MDI should be made available to the diabetic team and the patients to better tailor therapy, improve satisfaction and decrease the fear of hypoglycemia.

PMID:: 15151365; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Israel Medical Association

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. [Diabetes Care. 1999]
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Diabetes Care. 1999 Nov; 22(11):1779-84.
Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. [Pediatr Diabetes. 2008]
Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J. Pediatr Diabetes. 2008 Oct; 9(5):472-9. Epub 2008 Aug 20.
Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. [Pediatrics. 2003]
Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M. Pediatrics. 2003 Sep; 112(3 Pt 1):559-64.
Review [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. [Wiad Lek. 2004]
Review [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P. Wiad Lek. 2004; 57(5-6):263-6.
Review Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. [Diabetologia. 2008]
Review Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A. Diabetologia. 2008 Jun; 51(6):941-51. Epub 2008 Mar 20.

See reviews... See all...

Cited by 1 PubMed Central article

Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels. [J Diabetes Sci Technol. 2008]
Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels.
Chan A, Breton MD, Kovatchev BP. J Diabetes Sci Technol. 2008 Sep; 2(5):844-52.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Why pumps? Continuous subcutaneous insulin infusion for children and adolescents...
Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Isr Med Assoc J. 2004 May ;6(5):271-5.

PubMed
Crystallization and preliminary X-ray analysis of human endothelin.
Crystallization and preliminary X-ray analysis of human endothelin.
Acta Crystallogr B. 1992 Apr 1 ;48 ( Pt 2):239-40.

PubMed
[Arthroscopy in the diagnosis and therapy of wrist disorders].
[Arthroscopy in the diagnosis and therapy of wrist disorders].
Acta Chir Orthop Traumatol Cech. 2004 ;71(2):106-9.

PubMed
Validated procedure for simultaneous trace level determination of the anti-cance...
Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.
Rapid Commun Mass Spectrom. 2004 ;18(10):1017-23.

PubMed
A report from the international consensus on diagnosing and treating the infecte...
A report from the international consensus on diagnosing and treating the infected diabetic foot.
Diabetes Metab Res Rev. 2004 May-Jun ;20 Suppl 1:S68-77.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: